Blue Trust Inc. boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 31.3% during the fourth quarter, ...
Permian Basin Royalty Trust (NYSE:PBT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on ...
Debt Position: $7.8 billion in investment-grade ... interest paid expected to be around $250 million. Royalty Pharma PLC (NASDAQ:RPRX) delivered strong financial performance in 2024, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results